Live from ASH: Updates on the Treatment of Multiple Myeloma

Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de diciembre del 2008

Share article

> Imprima

Guest: Dan Vogl, M.D.
Date: Monday, December 8, 2008
Time: 10:00 – 10:30 am Pacific
Where to Listen:

Email questions in advance or during the live show to:

> Imprima

ASH: Novel Drug Beneficial in Multiple Myeloma

Oct 5, 2015 - In patients with relapsed or resistant multiple myeloma who have received up to three prior therapies excluding the first-generation proteasome inhibitor bortezomib, treatment with the second-generation proteasome inhibitor carfilzomib is associated a hig

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información

OncoLink Cancer Treatment and Resources